Literature DB >> 8774395

Intravenous immunoglobulin treatment in neurological diseases.

A Otten, M Vermeulen, P M Bossuyt, A Otten.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8774395      PMCID： PMC1073883          DOI： 10.1136/jnnp.60.4.359

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  38 in total

Review 1.  Polymyositis, dermatomyositis and inclusion-body myositis.

Authors:  M C Dalakas
Journal:  N Engl J Med       Date:  1991-11-21       Impact factor: 91.245

2.  High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study.

Authors:  P A van Doorn; A Brand; P F Strengers; J Meulstee; M Vermeulen
Journal:  Neurology       Date:  1990-02       Impact factor: 9.910

3.  Intravenous immunoglobulin: a single-blind trial in children with Lennox-Gastaut syndrome.

Authors:  N Illum; K Taudorf; C Heilmann; T Smith; K Wulff; B Mansa; P Platz
Journal:  Neuropediatrics       Date:  1990-05       Impact factor: 1.947

4.  Beneficial effects of plasma exchange in acute inflammatory polyradiculoneuropathy.

Authors:  P O Osterman; J Fagius; G Lundemo; P Pihlstedt; R Pirskanen; A Sidén; J Säfwenberg
Journal:  Lancet       Date:  1984-12-08       Impact factor: 79.321

5.  Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients.

Authors:  P Cherin; S Herson; B Wechsler; J C Piette; O Bletry; A Coutellier; J M Ziza; P Godeau
Journal:  Am J Med       Date:  1991-08       Impact factor: 4.965

6.  Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation.

Authors:  K M Sullivan; K J Kopecky; J Jocom; L Fisher; C D Buckner; J D Meyers; G W Counts; R A Bowden; F B Peterson; R P Witherspoon
Journal:  N Engl J Med       Date:  1990-09-13       Impact factor: 91.245

7.  Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment.

Authors:  P J Dyck; P C O'Brien; K F Oviatt; R P Dinapoli; J R Daube; J D Bartleson; B Mokri; T Swift; P A Low; A J Windebank
Journal:  Ann Neurol       Date:  1982-02       Impact factor: 10.422

8.  Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  P J Dyck; J Daube; P O'Brien; A Pineda; P A Low; A J Windebank; C Swanson
Journal:  N Engl J Med       Date:  1986-02-20       Impact factor: 91.245

9.  Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies.

Authors:  A Pestronk; V Chaudhry; E L Feldman; J W Griffin; D R Cornblath; E H Denys; M Glasberg; R W Kuncl; R K Olney; W C Yee
Journal:  Ann Neurol       Date:  1990-03       Impact factor: 10.422

Review 10.  Impairment, disability, or handicap in peripheral neuropathy: analysis of the use of outcome measures in clinical trials in patients with peripheral neuropathies.

Authors:  D S Molenaar; R de Haan; M Vermeulen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-08       Impact factor: 10.154
View more
  1 in total

Review 1.  Rare indications of IVIG therapy in neurological diseases based on case reports and small studies.

Authors:  Hayrettin Tumani
Journal:  J Neurol       Date:  2006-09       Impact factor: 4.849
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.